{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T07:10:10Z","timestamp":1779261010669,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T00:00:00Z","timestamp":1742601600000},"content-version":"am","delay-in-days":355,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.bulcan.2023.08.014","type":"journal-article","created":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T13:13:11Z","timestamp":1699276391000},"page":"347-355","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Genitourinary syndrome of menopause in patients with breast cancer treated by hormonotherapy: women's perception in ITAC, a French web-based survey"],"prefix":"10.1016","volume":"111","author":[{"given":"Pierre","family":"Mar\u00e8s","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camille","family":"Jauffret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carine","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrice","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Coussy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.bulcan.2023.08.014_bib0160","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/annonc\/mdz173","article-title":"Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-updagger","volume":"30","author":"Cardoso","year":"2019","journal-title":"Ann Oncol"},{"issue":"12","key":"10.1016\/j.bulcan.2023.08.014_bib0165","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.annonc.2020.09.010","article-title":"5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)","volume":"31","author":"Cardoso","year":"2020","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.bulcan.2023.08.014_bib0170","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12885-018-4080-8","article-title":"Trends in molecular subtypes of breast cancer: description of incidence rates between 2007 and 2012 from three French registries","volume":"18","author":"Cortet","year":"2018","journal-title":"BMC Cancer"},{"issue":"8","key":"10.1016\/j.bulcan.2023.08.014_bib0175","doi-asserted-by":"crossref","first-page":"e2013973","DOI":"10.1001\/jamanetworkopen.2020.13973","article-title":"Association of Endocrine Therapy With Overall Survival in Women With Small, Hormone Receptor\u2013Positive, ERBB2-Negative Breast Cancer","volume":"3","author":"Ma","year":"2020","journal-title":"JAMA Network Open"},{"issue":"5","key":"10.1016\/j.bulcan.2023.08.014_bib0180","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1200\/JCO.18.01160","article-title":"Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update","volume":"37","author":"Burstein","year":"2019","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.bulcan.2023.08.014_bib0185","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s10549-011-1351-3","article-title":"Aromatase inhibitor therapy: toxicities and management strategies in the treatment of postmenopausal women with hormone-sensitive early breast cancer","volume":"126","author":"Dent","year":"2011","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"10.1016\/j.bulcan.2023.08.014_bib0190","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1159\/000509362","article-title":"Endocrine Therapy in Early Breast Cancer","volume":"15","author":"Krauss","year":"2020","journal-title":"Breast Care (Basel)"},{"issue":"6","key":"10.1016\/j.bulcan.2023.08.014_bib0195","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.ajog.2016.07.045","article-title":"Genitourinary syndrome of menopause: an overview of clinical manifestations, pathophysiology, etiology, evaluation, and management","volume":"215","author":"Gandhi","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"10","key":"10.1016\/j.bulcan.2023.08.014_bib0200","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/GME.0000000000000329","article-title":"Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society","volume":"21","author":"Portman","year":"2014","journal-title":"Menopause"},{"issue":"5","key":"10.1016\/j.bulcan.2023.08.014_bib0205","doi-asserted-by":"crossref","first-page":"224","DOI":"10.5694\/j.1326-5377.2007.tb00877.x","article-title":"Communicating about patient sexuality and intimacy after cancer: mismatched expectations and unmet needs","volume":"186","author":"Hordern","year":"2007","journal-title":"Med J Aust"},{"issue":"8","key":"10.1016\/j.bulcan.2023.08.014_bib0210","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.clbc.2017.05.008","article-title":"Vaginal Atrophy in Breast Cancer Survivors: Attitude and Approaches Among Oncologists","volume":"17","author":"Biglia","year":"2017","journal-title":"Clin Breast Cancer"},{"issue":"6","key":"10.1016\/j.bulcan.2023.08.014_bib0215","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1007\/s00520-019-05272-4","article-title":"Vulvovaginal atrophy (VVA) in breast cancer survivors (BCS) is still an unmet medical need: results of an Italian Delphi Panel","volume":"28","author":"Biglia","year":"2020","journal-title":"Support Care Cancer"},{"issue":"2","key":"10.1016\/j.bulcan.2023.08.014_bib0220","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3109\/13697137.2015.1107039","article-title":"Vulvar and vaginal atrophy in four European countries: evidence from the European REVIVE Survey","volume":"19","author":"Nappi","year":"2016","journal-title":"Climacteric"},{"key":"10.1016\/j.bulcan.2023.08.014_bib0225","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.maturitas.2016.06.010","article-title":"The REVIVE (REal Women's VIews of Treatment Options for Menopausal Vaginal ChangEs) survey in Europe: Country-specific comparisons of postmenopausal women's perceptions, experiences and needs","volume":"91","author":"Nappi","year":"2016","journal-title":"Maturitas"},{"issue":"2","key":"10.1016\/j.bulcan.2023.08.014_bib0230","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3816\/CBC.2009.n.020","article-title":"Prevalence and severity of urogenital symptoms in postmenopausal women receiving endocrine therapy for breast cancer","volume":"9","author":"Chin","year":"2009","journal-title":"Clin Breast Cancer"},{"issue":"2","key":"10.1016\/j.bulcan.2023.08.014_bib0235","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1188\/21.ONF.229-241","article-title":"Genitourinary Symptoms in Breast Cancer Survivors: Prevalence, Correlates, and Relationship With Sexual Functioning","volume":"48","author":"Sheng","year":"2021","journal-title":"Oncol Nurs Forum"},{"issue":"2","key":"10.1016\/j.bulcan.2023.08.014_bib0240","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/GME.0b013e31826560da","article-title":"Sexual dysfunction in women on adjuvant endocrine therapy after breast cancer","volume":"20","author":"Baumgart","year":"2013","journal-title":"Menopause"},{"issue":"3","key":"10.1016\/j.bulcan.2023.08.014_bib0245","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s10549-006-9260-6","article-title":"Quality of life of postmenopausal women in the ATAC (\u201cArimidex\u201d, tamoxifen, alone or in combination) trial after completion of 5 years\u2019 adjuvant treatment for early breast cancer","volume":"100","author":"Cella","year":"2006","journal-title":"Breast Cancer Res Treat"},{"issue":"24","key":"10.1016\/j.bulcan.2023.08.014_bib0250","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1200\/JCO.19.01758","article-title":"Serum Detection of Nonadherence to Adjuvant Tamoxifen and Breast Cancer Recurrence Risk","volume":"38","author":"Pistilli","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bulcan.2023.08.014_bib0255","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1186\/2193-1801-3-282","article-title":"Early discontinuation of endocrine therapy for breast cancer: who is at risk in clinical practice?","volume":"3","author":"Kemp","year":"2014","journal-title":"Springerplus"},{"issue":"10","key":"10.1016\/j.bulcan.2023.08.014_bib0260","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1210\/jc.2017-01138","article-title":"Managing Menopausal Symptoms and Associated Clinical Issues in Breast Cancer Survivors","volume":"102","author":"Santen","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.bulcan.2023.08.014_bib0265","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1200\/JOP.18.00710","article-title":"Managing Genitourinary Syndrome of Menopause in Breast Cancer Survivors Receiving Endocrine Therapy","volume":"15","author":"Sussman","year":"2019","journal-title":"J Oncol Pract"},{"issue":"2","key":"10.1016\/j.bulcan.2023.08.014_bib0270","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1080\/13697137.2017.1421923","article-title":"Treatment of vaginal atrophy with estriol and lactobacilli combination: a clinical review","volume":"21","author":"Mueck","year":"2018","journal-title":"Climacteric"},{"issue":"3","key":"10.1016\/j.bulcan.2023.08.014_bib0275","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1093\/asj\/sjx138","article-title":"Nonsurgical Vulvovaginal Rejuvenation With Radiofrequency and Laser Devices: A Literature Review and Comprehensive Update for Aesthetic Surgeons","volume":"38","author":"Qureshi","year":"2018","journal-title":"Aesthet Surg J"},{"key":"10.1016\/j.bulcan.2023.08.014_bib0280","doi-asserted-by":"crossref","first-page":"988","DOI":"10.3332\/ecancer.2019.988","article-title":"A systematic review of laser therapy for vulvovaginal atrophy\/genitourinary syndrome of menopause in breast cancer survivors","volume":"13","author":"Knight","year":"2019","journal-title":"Ecancermedicalscience"},{"issue":"2","key":"10.1016\/j.bulcan.2023.08.014_bib0285","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3390\/jpm5020050","article-title":"Atrophic vaginitis in breast cancer survivors: a difficult survivorship issue","volume":"5","author":"Lester","year":"2015","journal-title":"J Pers Med"},{"key":"10.1016\/j.bulcan.2023.08.014_bib0290","unstructured":"US Food and Drug Administration. Statement from FDA Commissioner Scott Gottlieb,M.D., on efforts to safeguard women's health from deceptive health claims and significant risks related to devices marketed for use in medical procedures for vaginal rejuvenation. 2018."},{"issue":"3","key":"10.1016\/j.bulcan.2023.08.014_bib0295","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1097\/AOG.0000000000001351","article-title":"ACOG Committee Opinion No. 659: The Use of Vaginal Estrogen in Women With a History of Estrogen-Dependent Breast Cancer","volume":"127","year":"2016","journal-title":"Obstet Gynecol"},{"issue":"11","key":"10.1016\/j.bulcan.2023.08.014_bib0300","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1080\/14737140.2018.1520096","article-title":"Managing side effects in adjuvant endocrine therapy for breast cancer","volume":"18","author":"Condorelli","year":"2018","journal-title":"Expert Rev Anticancer Ther"},{"issue":"7","key":"10.1016\/j.bulcan.2023.08.014_bib0305","doi-asserted-by":"crossref","first-page":"e303","DOI":"10.1016\/S1470-2045(20)30666-5","article-title":"Evidence-based approaches for the management of side-effects of adjuvant endocrine therapy in patients with breast cancer","volume":"22","author":"Franzoi","year":"2021","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.bulcan.2023.08.014_bib0310","doi-asserted-by":"crossref","first-page":"71","DOI":"10.5306\/wjco.v13.i2.71","article-title":"Management of genitourinary syndrome of menopause in breast cancer survivors: An update","volume":"13","author":"Lubian Lopez","year":"2022","journal-title":"World J Clin Oncol"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455123003818?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455123003818?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,23]],"date-time":"2024-03-23T08:59:04Z","timestamp":1711184344000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455123003818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0007455123003818"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2023.08.014","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genitourinary syndrome of menopause in patients with breast cancer treated by hormonotherapy: women's perception in ITAC, a French web-based survey","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2023.08.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}